Integer (ITGR) to Release Earnings on Thursday

Integer (NYSE:ITGR - Get Free Report) will likely be releasing its Q1 2025 earnings data before the market opens on Thursday, April 24th. Analysts expect Integer to post earnings of $1.28 per share and revenue of $428.51 million for the quarter. Integer has set its FY 2025 guidance at 5.840-6.200 EPS.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $449.50 million for the quarter, compared to analyst estimates of $446.28 million. On average, analysts expect Integer to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Integer Trading Up 2.3 %

NYSE ITGR traded up $2.68 during trading hours on Tuesday, reaching $118.12. The company had a trading volume of 325,604 shares, compared to its average volume of 348,344. The stock has a 50-day moving average of $120.73 and a 200 day moving average of $130.42. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62. Integer has a 1-year low of $104.93 and a 1-year high of $146.36. The stock has a market capitalization of $4.12 billion, a P/E ratio of 35.16, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ITGR shares. Oppenheimer downgraded shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Raymond James started coverage on shares of Integer in a report on Friday, March 28th. They issued an "outperform" rating and a $145.00 price target on the stock. Benchmark upped their price objective on shares of Integer from $140.00 to $150.00 and gave the company a "buy" rating in a research note on Friday, February 21st. KeyCorp dropped their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a report on Monday. Finally, Truist Financial reduced their price objective on Integer from $163.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 11th. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $145.00.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.